4basebio PLC header image

4basebio PLC

88Q

Equity

ISIN GB00BMCLYF79 / Valor 112829117

Xetra (2026-05-05)
EUR 5.62-3.86%

4basebio PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

4basebio PLC, formerly known as 4basebio SLU, is a company that specializes in the development and sale of DNA products. The company holds intellectual property related to DNA technologies, with a focus on DNA amplification and sequencing. The Madrid-based team has expertise in synthetic DNA development, utilizing technologies like TruePrime© for efficient and cost-effective production of high-quality DNA. Professor Luis Blanco, a renowned researcher in DNA polymerases, played a key role in the company's origins and continues to contribute to its development agenda. 4basebio PLC is dedicated to advancing its platform development and scaling production to commercial levels, positioning itself as a leader in the DNA products market.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-57.4%1Y
-20.8%3Y
%5Y

Performance

34.8%1Y
31.9%3Y
37.3%5Y

Volatility

Market cap

103 M

Market cap (USD)

Daily traded volume (Shares)

2,166

Daily traded volume (Shares)

1 day high/low

14.2 / 14.2

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.07%USD 301.11
BeiGene Ltd
BeiGene Ltd BeiGene Ltd Valor: 30165310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%USD 297.49
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.84%USD 168.71
Icon PLC
Icon PLC Icon PLC Valor: 1017575
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.35%USD 121.32
Royalty Pharma PLC
Royalty Pharma PLC Royalty Pharma PLC Valor: 55041695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 50.44
Viatris Inc
Viatris Inc Viatris Inc Valor: 58198423
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.11%USD 15.52
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.75%USD 56.95
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.58%USD 10.61
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.73%USD 232.30
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.78%USD 16.75